4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-038277
Director sold 9,000 shares at an average $93.55 ($841,926)
- Director acquired 9,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foster-Cheek Kaye I Director | 2018-06-14 | Option exercise | +9,000 | $50.73 | $456,570 | 11,200 | D |
| Foster-Cheek Kaye I Director | 2018-06-14 | Sale | −2,181 | $92.62 | $202,004 | 9,019 | D |
| Foster-Cheek Kaye I Director | 2018-06-14 | Sale | −5,980 | $93.78 | $560,804 | 3,039 | D |
| Foster-Cheek Kaye I Director | 2018-06-14 | Sale | −839 | $94.30 | $79,118 | 2,200 | D |
| Derivatives | |||||||
| Foster-Cheek Kaye I Director | 2018-06-14 | Option exercise · Stock option (right to buy) | −9,000 | 0 | D | ||
| Open-market sales · 9,000 sh · avg $93.55 · $841,926 | |||||||
Loading xslF345X03/doc4.xml…